Essential Amino Acids (EAAs) trials recruiting now
2 registrations that name essential Amino Acids as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.
Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.
Filter 2 registrations
Status
Phase
1US sites across 1 state
1
2 to 4
5 to 19
20 or more
All 2 registrations
RecruitingNCT07459504
SMART Diets for MASLD
Phase 2
Michigan State University
About 102 people
Starts Jun 2026 (estimated)
In plain words A Phase 2 study of essential Amino Acids in people 11 to 17, run by Michigan State University. It plans to enroll about 102 people at 1 US site.
Who it lists and where
Who the trial lists, as registered
Lists people 11 to 17. Conditions: Metabolic-dysfunction Associated Steatotic Liver Disease.
Children 11 to 17-years-old at the time of consenting
Hepatic Steatosis by MRI greater than or equal to 8% on baseline MRI
At least 1 of the following cardiometabolic risk factors: BMI greater than or equal to 85th percentile for age/sex or WC greater than 95th percentile, Abnormal cholesterol or triglyceride levels, Blood pressure BP greater than or equal to…
ALT greater than or equal to 40 U/L
4 more inclusion criteria and the exclusion criteria are on the listing.
This phase 2 trial is a single-site sequential, multiple assignment, randomized trial (SMART) to test and construct a high-quality adaptive intervention of essential amino acids (EAA) and/or Low Sugar Diet for children with metabolic dysfunction associated steatotic liver disease (MASLD) and increased cardiometabolic risk. The basis for the trial includes high-quality pilot data in both EAA for hepatic steatosis and a low sugar diet for hepatic steatosis. The full summary is on the listing.
Where, as registered
1 US site in 1 state.
RecruitingNCT07543016
Amino Acids and Exercise in FSHD
No phase
University of Pavia
About 48 people
Started Apr 8, 2026
In plain words A study of essential Amino Acids in people 18 to 50, run by University of Pavia. It plans to enroll about 48 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 50; healthy volunteers accepted. Conditions: FSH Muscular Dystrophy; Muscular Dystrophy.
Subjects of both sexes with a diagnosis of FSHD, confirmed by genetic testing.
Age between 18 and 50 years.
Belonging to clinical category A among the four defined in the Comprehensive Clinical Evaluation Form. These patients present the most characteristic signs of the disease: muscle weakness of the facial and scapular girdle.
Clinical score ranging from 2 to 5.
3 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Essential Amino Acids Supplementation intervention; Exercise; Diet; Placebo Control
Registered summary
This study evaluates whether amino acid supplementation, combined with a structured diet and exercise program, improves body composition (increased muscle mass and reduced fat mass) and physical performance in individuals with facioscapulohumeral muscular dystrophy (FSHD). The study also compares responses to the intervention between individuals with FSHD and healthy individuals matched for age and sex.
Where, as registered
No US site; Italy (1).
ClinicalTrials.gov lists 81 open registrations for this search, including ones where essential Amino Acids is not a study arm or that are past the 2 we keep. Search them on ClinicalTrials.gov (opens in new tab).